Provided by Tiger Fintech (Singapore) Pte. Ltd.

InspireMD

2.24
+0.01000.45%
Post-market: 2.240.00000.00%16:18 EDT
Volume:44.75K
Turnover:100.84K
Market Cap:68.62M
PE:-2.84
High:2.29
Open:2.26
Low:2.20
Close:2.23
Loading ...

InspireMD Q1 Operating Expenses USD 11.752 Million

THOMSON REUTERS
·
09 May

InspireMD Q1 Gross Profit USD 292 Thousand

THOMSON REUTERS
·
09 May

InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
07 May

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

GlobeNewswire
·
30 Apr

BRIEF-Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Apr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Apr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
08 Apr

InspireMD Files $200 Million Mixed Shelf

MT Newswires Live
·
02 Apr

BRIEF-InspireMD Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing

Reuters
·
02 Apr

InspireMD files $200M mixed securities shelf

TIPRANKS
·
02 Apr

InspireMD Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing

THOMSON REUTERS
·
02 Apr

InspireMD Inc: Prospectus Supplement Covering Offering Shares of Common Stock of up to $75 Mln

THOMSON REUTERS
·
02 Apr

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
26 Mar

InspireMD Full Year 2024 Earnings: US$0.76 loss per share (vs US$0.82 loss in FY 2023)

Simply Wall St.
·
13 Mar

InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ...

GuruFocus.com
·
13 Mar

Lake Street Remains a Buy on InspireMD (NSPR)

TIPRANKS
·
10 Mar

InspireMD Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
10 Mar

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
26 Feb

InspireMD announces inducement grants under Nasdaq listing rule

TIPRANKS
·
25 Feb

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
25 Feb